Sangamo Therapeutics Stock Forecast - 20 Period Moving Average

SGMO Stock  USD 1.94  0.01  0.51%   
The 20 Period Moving Average forecasted value of Sangamo Therapeutics on the next trading day is expected to be 2.04 with a mean absolute deviation of 0.42 and the sum of the absolute errors of 17.76. Sangamo Stock Forecast is based on your current time horizon. Although Sangamo Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sangamo Therapeutics' systematic risk associated with finding meaningful patterns of Sangamo Therapeutics fundamentals over time.
  
At this time, Sangamo Therapeutics' Receivables Turnover is very stable compared to the past year. As of the 12th of December 2024, Asset Turnover is likely to grow to 1.12, while Inventory Turnover is likely to drop (0.13). . As of the 12th of December 2024, Common Stock Shares Outstanding is likely to grow to about 183.2 M, though Net Loss is likely to grow to (164.4 M).
A commonly used 20-period moving average forecast model for Sangamo Therapeutics is based on a synthetically constructed Sangamo Therapeuticsdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Sangamo Therapeutics 20 Period Moving Average Price Forecast For the 13th of December 2024

Given 90 days horizon, the 20 Period Moving Average forecasted value of Sangamo Therapeutics on the next trading day is expected to be 2.04 with a mean absolute deviation of 0.42, mean absolute percentage error of 0.33, and the sum of the absolute errors of 17.76.
Please note that although there have been many attempts to predict Sangamo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sangamo Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Sangamo Therapeutics Stock Forecast Pattern

Backtest Sangamo TherapeuticsSangamo Therapeutics Price PredictionBuy or Sell Advice 

Sangamo Therapeutics Forecasted Value

In the context of forecasting Sangamo Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sangamo Therapeutics' downside and upside margins for the forecasting period are 0.02 and 11.48, respectively. We have considered Sangamo Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.94
2.04
Expected Value
11.48
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Sangamo Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sangamo Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria82.0698
BiasArithmetic mean of the errors -0.2983
MADMean absolute deviation0.4228
MAPEMean absolute percentage error0.2084
SAESum of the absolute errors17.757
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Sangamo Therapeutics 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Sangamo Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sangamo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.112.2611.71
Details
Intrinsic
Valuation
LowRealHigh
0.163.1112.56
Details
8 Analysts
Consensus
LowTargetHigh
5.996.587.30
Details

Other Forecasting Options for Sangamo Therapeutics

For every potential investor in Sangamo, whether a beginner or expert, Sangamo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sangamo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sangamo. Basic forecasting techniques help filter out the noise by identifying Sangamo Therapeutics' price trends.

Sangamo Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sangamo Therapeutics stock to make a market-neutral strategy. Peer analysis of Sangamo Therapeutics could also be used in its relative valuation, which is a method of valuing Sangamo Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Sangamo Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sangamo Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sangamo Therapeutics' current price.

Sangamo Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Sangamo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sangamo Therapeutics shares will generate the highest return on investment. By undertsting and applying Sangamo Therapeutics stock market strength indicators, traders can identify Sangamo Therapeutics entry and exit signals to maximize returns.

Sangamo Therapeutics Risk Indicators

The analysis of Sangamo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sangamo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sangamo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Sangamo Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sangamo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sangamo Stock

  0.61ESPR Esperion TherapeuticsPairCorr

Moving against Sangamo Stock

  0.85MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.79LLY Eli LillyPairCorr
  0.79PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.74JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.67VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Sangamo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sangamo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sangamo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sangamo Therapeutics to buy it.
The correlation of Sangamo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sangamo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sangamo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sangamo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock:
Check out Historical Fundamental Analysis of Sangamo Therapeutics to cross-verify your projections.
To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.24)
Revenue Per Share
0.066
Quarterly Revenue Growth
(0.95)
Return On Assets
(0.58)
Return On Equity
(1.94)
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.